Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin Combination for IFI in Allo-HSCT
NCT01501708Phase 2Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Dec 2011
- Primary completion
- Jun 2017
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of caspofungin in invasive fungal infection (IFI), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
caspofungin
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT01501708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01501708.